SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-015730
Filing Date
2022-04-26
Accepted
2022-04-26 16:43:57
Documents
13
Period of Report
2022-04-26
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K flgt-8k_20220426.htm   iXBRL 8-K 37234
2 EX-2.1 flgt-ex21_7.htm EX-2.1 1035632
  Complete submission text file 0001564590-22-015730.txt   1381195

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA flgt-20220426.xsd EX-101.SCH 5613
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE flgt-20220426_lab.xml EX-101.LAB 18574
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE flgt-20220426_pre.xml EX-101.PRE 11053
7 EXTRACTED XBRL INSTANCE DOCUMENT flgt-8k_20220426_htm.xml XML 3422
Mailing Address 4978 SANTA ANITA AVENUE, SUITE 205 TEMPLE CITY CA 91780
Business Address 4978 SANTA ANITA AVENUE, SUITE 205 TEMPLE CITY CA 91780 626-350-0537
Fulgent Genetics, Inc. (Filer) CIK: 0001674930 (see all company filings)

IRS No.: 812621304 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37894 | Film No.: 22854963
SIC: 8071 Services-Medical Laboratories